A Study of Population Pharmacokinetics of Docetaxel (Taxotere) in Caucasian and African-American Cancer Patients

Trial Profile

A Study of Population Pharmacokinetics of Docetaxel (Taxotere) in Caucasian and African-American Cancer Patients

Completed
Phase of Trial: Phase II

Latest Information Update: 18 Jul 2016

At a glance

  • Drugs Docetaxel (Primary)
  • Indications Bladder cancer; Breast cancer; Head and neck cancer; Lung cancer; Solid tumours
  • Focus Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 22 Jan 2008 Status changed from in progress to completed.
    • 11 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top